---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-24-000851"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2024-08-27T23:59:59+00:00"
generated_at: "2026-05-31T07:21:19.745047+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma stockholders re-elect two directors, ratify auditor, approve 5M share grant

## Summary
- Richard Prins (26,116,740 for) and Terry Lierman (27,800,503 for) re-elected as Class B directors until 2027.
- Ratified Manohar Chowdhry & Associates as independent registered public accounting firm for 2025 fiscal year (42,587,128 for).
- Approved grant of up to 5,000,000 common shares to employees, advisors, directors, and consultants.
- Non-binding advisory vote indicates executive compensation votes will be held every three years.
- Approximately 56.6% of outstanding shares (42,811,367) voted; 14,877,728 broker non-votes.

## SEC filing metadata
- accession: 0001185185-24-000851
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2024-08-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/0001185185-24-000851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518524000851/igc20240826_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-24-000851
- JSON: https://secwatch.observer/filing/0001185185-24-000851.json
- Plain text: https://secwatch.observer/filing/0001185185-24-000851.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.